Characteristics and Mechanism of Acute Ischemic Stroke in NAVF Patients With Prior Oral Anticoagulant Therapy

被引:1
|
作者
Xue, Sufang [1 ]
Na, Risu [2 ]
Dong, Jing [1 ]
Wei, Min [1 ]
Kong, Qi [1 ]
Wang, Qiujia [1 ]
Qiu, Xue [3 ]
Li, Fangyu [1 ]
Song, Haiqing [1 ,4 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Tongliao City Hosp, Dept Neurol, Tongliao, Peoples R China
[3] Shuangqiao Hosp, Dept Neurol, Beijing, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Changchun St 45, Beijing 100053, Peoples R China
关键词
prior oral anticoagulant therapy; acute ischemic stroke; nonvalvular atrial fibrillation; competing stroke mechanism; CAROTID-ARTERY STENOSIS; ATRIAL-FIBRILLATION; PREDICTING STROKE; SUBGROUP ANALYSIS; PREVENTION; WARFARIN; RISK; CLASSIFICATION; VALIDATION; RECURRENCE;
D O I
10.1097/NRL.0000000000000504
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We aimed to analyze the characteristics and mechanisms of acute ischemic stroke (AIS) in patients with nonvalvular atrial fibrillation (NVAF) who received prior anticoagulant therapy.Methods: We retrospectively analyzed the data of patients with NVAF and AIS between January 2016 and December 2021. Patients were divided into non-anticoagulant, adequate anticoagulant, and insufficient anticoagulant groups according to their prior anticoagulant status. Patients with prior anticoagulant therapy were further divided into warfarin and direct oral anticoagulant groups.Results: A total of 749 patients (661 without anticoagulants, 33 with adequate anticoagulants, and 55 with insufficient anticoagulants) were included. Patients with adequate anticoagulant had a milder National Institute of Health Stroke Scale at presentation (P=0.001) and discharge (P=0.003), a higher proportion of Modified Rankin Scale (mRS) <= 2 at discharge (P=0.011), and lower rates of massive infarction (P=0.008) than patients without anticoagulant. Compared with the non-anticoagulant group, the proportion of intravenous thrombolysis was significantly lower in the adequate anticoagulant (P<0.001) and insufficient anticoagulant (P=0.009) groups. Patients in the adequate anticoagulant group had higher rates of responsible cerebral atherosclerotic stenosis (P=0.001 and 0.006, respectively) and competing large artery atherosclerotic mechanisms (P=0.006 and 0.009, respectively) than those in the other 2 groups. Compared with warfarin, direct oral anticoagulant was associated with higher rates of Modified Rankin Scale <= 2 at discharge (P=0.003).Conclusions: Adequate anticoagulant therapy may be associated with milder stroke severity and better outcomes at discharge in patients with NVAF. Competing large artery atherosclerotic mechanisms may be associated with anticoagulant failure in patients with NAVF with prior adequate anticoagulant therapy.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [21] Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation
    Sakamoto, Yuki
    Okubo, Seiji
    Sekine, Tetsuro
    Nito, Chikako
    Suda, Satoshi
    Matsumoto, Noriko
    Nishiyama, Yasuhiro
    Aoki, Junya
    Shimoyama, Takashi
    Kanamaru, Takuya
    Suzuki, Kentaro
    Mishina, Masahiro
    Kimura, Kazumi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (17):
  • [22] The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
    Kato, Yuji
    Hayashi, Takeshi
    Tanahashi, Norio
    Takao, Masaki
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (06): : 1490 - 1496
  • [23] Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke
    Shrestha, Shreya
    Coy, Shannon
    Bekelis, Kimon
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (09) : 1377 - 1391
  • [24] CHA2DS2-VASc score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke
    Imaoka, Yukihiro
    Ren, Nice
    Ogata, Soshiro
    Imamura, Hirotoshi
    Kaku, Yasuyuki
    Arimura, Koichi
    Watanabe, Shogo
    Kiyoshige, Eri
    Nishimura, Kunihiro
    Kobashi, Syoji
    Ihara, Masafumi
    Kamiyama, Kenji
    Morimoto, Masafumi
    Ohta, Tsuyoshi
    Endo, Hidenori
    Matsumaru, Yuji
    Sakai, Nobuyuki
    Kitazono, Takanari
    Fujimoto, Shigeru
    Ogasawara, Kuniaki
    Iihara, Koji
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024,
  • [25] Prior antiplatelet or anticoagulant therapy and mortality in stroke
    Kwok, Chun Shing
    Skinner, Jane
    Metcalf, Anthony K.
    Potter, John F.
    Myint, Phyo Kyaw
    HEART, 2012, 98 (09) : 712 - 717
  • [26] 2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
    Park, Hong-Kyun
    Ko, Sang-Bae
    Jung, Keun-Hwa
    Jang, Min Uk
    Kim, Dae-Hyun
    Kim, Joon-Tae
    Choi, Jay Chol
    Jeong, Hye Seon
    Kim, Chulho
    Heo, Ji Hoe
    Rha, Joung-Ho
    Kwon, Sun U.
    Kim, Jong S.
    Lee, Byung-Chul
    Bae, Hee-Joon
    Yoon, Byung-Woo
    Hong, Keun-Sik
    JOURNAL OF STROKE, 2022, 24 (01) : 166 - +
  • [27] Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
    Benz, Alexander P.
    Hohnloser, Stefan H.
    Eikelboom, John W.
    Carnicelli, Anthony P.
    Giugliano, Robert P.
    Granger, Christopher B.
    Harrington, Josephine
    Hijazi, Ziad
    Morrow, David A.
    Patel, Manesh R.
    Seiffge, David J.
    Shoamanesh, Ashkan
    Wallentin, Lars
    Yi, Qilong
    Connolly, Stuart J.
    EUROPEAN HEART JOURNAL, 2023, 44 (20) : 1807 - 1814
  • [28] Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
    Yoo, Han Soo
    Kim, Young Dae
    Lee, Hye Sun
    Song, Dongbeom
    Song, Tae Jin
    Kim, Byung Moon
    Kim, Dong Joon
    Kim, Dong Ik
    Heo, Ji Hoe
    Nam, Hyo Suk
    JOURNAL OF STROKE, 2013, 15 (03) : 182 - 188
  • [29] Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
    Chang, Po-Yin
    Wang, Wei-Ting
    Wu, Wei-Lun
    Chang, Hui-Chin
    Chen, Chen-Huan
    Tsai, Yi-Wen
    Chiou, Shih-Hwa
    Lip, Gregory Y. H.
    Cheng, Hao-Min
    Chiang, Chern-En
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 939 - 950
  • [30] Oral Antiplatelet Therapy for Acute Ischemic Stroke
    Minhas, Jatinder S.
    Chithiramohan, Tamara
    Wang, Xia
    Barnes, Sam C.
    Clough, Rebecca H.
    Kadicheeni, Meeriam
    Beishon, Lucy C.
    Robinson, Thompson G.
    STROKE, 2022, 53 (10) : E453 - E454